Your browser is no longer supported. Please, upgrade your browser.
SNY Sanofi monthly Stock Chart
SNY [NASD]
Sanofi
Index- P/E21.06 EPS (ttm)1.99 Insider Own16.40% Shs Outstand2.54B Perf Week-0.97%
Market Cap106.36B Forward P/E11.88 EPS next Y3.53 Insider Trans0.00% Shs Float2.23B Perf Month-2.69%
Income4.99B PEG2.70 EPS next Q0.74 Inst Own7.80% Short Float0.09% Perf Quarter2.09%
Sales40.79B P/S2.61 EPS this Y15.50% Inst Trans0.03% Short Ratio1.31 Perf Half Y-0.62%
Book/sh26.25 P/B1.60 EPS next Y8.62% ROA- Target Price52.67 Perf Year0.02%
Cash/sh- P/C- EPS next 5Y7.80% ROE- 52W Range40.19 - 45.62 Perf YTD-3.36%
Dividend1.74 P/FCF- EPS past 5Y4.80% ROI5.00% 52W High-8.04% Beta0.59
Dividend %4.15% Quick Ratio- Sales past 5Y2.70% Gross Margin68.30% 52W Low4.38% ATR0.60
Employees104226 Current Ratio- Sales Q/Q7.20% Oper. Margin18.30% RSI (14)44.18 Volatility1.08% 1.11%
OptionableYes Debt/Eq- EPS Q/Q12.00% Profit Margin16.40% Rel Volume1.24 Prev Close41.57
ShortableYes LT Debt/Eq- EarningsJul 29 BMO Payout0.00% Avg Volume1.50M Price41.95
Recom1.50 SMA20-2.65% SMA50-0.92% SMA200-2.76% Volume1,860,760 Change0.91%
Dec-11-18Upgrade Jefferies Hold → Buy
Nov-01-18Upgrade Barclays Underweight → Equal Weight
Oct-09-18Initiated Guggenheim Neutral
Sep-10-18Upgrade BofA/Merrill Neutral → Buy
Aug-10-18Upgrade Citigroup Neutral → Buy
Mar-23-18Upgrade Liberum Hold → Buy
Jan-23-18Downgrade Barclays Equal Weight → Underweight
Dec-06-17Downgrade BofA/Merrill Buy → Neutral
Dec-01-17Downgrade Morgan Stanley Overweight → Underweight
Nov-15-17Upgrade Barclays Underweight → Equal Weight
Aug-30-17Upgrade HSBC Securities Reduce → Hold
May-11-17Downgrade Berenberg Buy → Hold
Apr-07-17Downgrade HSBC Securities Hold → Reduce
Apr-06-17Initiated Argus Buy $50
Mar-09-17Initiated Liberum Hold
Nov-07-16Initiated Goldman Neutral
Sep-23-16Initiated Piper Jaffray Neutral
Sep-15-16Resumed JP Morgan Underweight
Sep-13-16Upgrade Exane BNP Paribas Underperform → Neutral
Sep-08-16Upgrade Berenberg Hold → Buy
Jul-18-19 10:10AM  New Strong Buy Stocks for July 18th Zacks
Jul-17-19 11:20AM  Inovio (INO) Ends Some Early-Stage R&D Programs, Cuts Jobs Zacks
10:24AM  Merck's Antibiotic Recarbrio Gets FDA Nod for Infections Zacks
Jul-15-19 05:43PM  AstraZeneca's Farxiga Gets CRL from FDA for Type I Diabetes Zacks
07:00AM  AI Drug Hunters Could Give Big Pharma a Run for Its Money Bloomberg
Jul-12-19 09:47AM  Aimmune Down on Negative ICER Review on Allergy Candidate Zacks
09:30AM  SNY or PFE: Which Is the Better Value Stock Right Now? Zacks
09:10AM  Are Investors Undervaluing Sanofi (SNY) Right Now? Zacks
08:36AM  Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY Zacks
Jul-11-19 11:16AM  FDA Accepts Sanofi's BLA for Myeloma Candidate to Review Zacks
Jul-10-19 11:24AM  Court Ruling Topples Trump Order, No Price Display in TV Ads Zacks
07:17AM  The Daily Biotech Pulse: Jazz Buys Tumor Drug Program, Sanofi's BLA For Multiple Myeloma Drug Accepted, Positive Results For ViiV Benzinga
Jul-09-19 10:07AM  How this Peninsula biotech plans to turn a $100 million round into 'next generation' of cancer drugs American City Business Journals
Jul-05-19 09:32AM  Pharma Stock Roundup: PFE's Regulatory/Pipeline Updates, CHMP Nod for Several Drugs Zacks
Jul-04-19 10:26AM  Glaxo's Dovato Wins EU Nod, RA Candidate Enters Phase III Zacks
Jul-03-19 01:54PM  Roche's Flu Medicine Xofluza Meets Goal in Study on Kids Zacks
01:40PM  5 Dividend Stocks to Buy From Across the Globe InvestorPlace
11:49AM  Euro-Area's Biggest Companies Index Enters Bull Market on Trade Bloomberg
10:22AM  Amarin (AMRN) Issues Update on Q2 Sales, Raises '19 Guidance Zacks
Jul-02-19 05:27PM  Livongo Leading Digital Health Charge Back Into Public Market GuruFocus.com
04:56PM  Pfizer's Eucrisa Proves Safety in Kids with Atopic Dermatitis Zacks
11:31AM  CORRECTED-Pfizer, Sanofi, to boost South African Biovac's vaccine output Reuters
09:31AM  Regeneron/Sanofi's Libtayo Gets EU Approval for Skin Cancer Zacks
09:09AM  Pfizer, Sanofi, to boost South African Biovac's vaccine output Reuters
Jul-01-19 11:00PM  Patent panic gives green light to mega pharma deals Financial Times
11:00AM  Regeneron/Sanofi's Dupixent Gets Positive CHMP Recommendation Zacks
Jun-28-19 10:10AM  Novavax (NVAX) Seeks Accelerated Approval Pathway for NanoFlu Zacks
Jun-27-19 10:30AM  FDA Accepts Sanofi's BLA for Meningitis Vaccine to Review Zacks
07:39AM  Regeneron & Sanofi Get FDA Nod for Dupixent Label Expansion Zacks
07:26AM  The Daily Biotech Pulse: Verrica Rallies, Aclaris Flunked Hair Loss Study, 3 Biotechs To IPO Benzinga
Jun-26-19 01:46PM  UPDATE 2-FDA approves expanded label for Regeneron/Sanofi's Dupixent Reuters
01:34PM  FDA approves expanded label for Regeneron/Sanofi's Dupixent Reuters
01:30PM  FDA approves Dupixent® (dupilumab) for chronic rhinosinusitis with nasal polyposis PR Newswire
Jun-25-19 11:39AM  Acer Therapeutics stock plummets 80 percent on FDA rejection American City Business Journals
09:24AM  Regeneron Pharma Turnaround Gains Steam Investopedia
Jun-22-19 09:33AM  This would be the worst-case scenario for health stocks, according to UBS MarketWatch
Jun-21-19 04:15PM  Regeneron And Sanofi Tried To Outperform Themselves And Couldn't Investor's Business Daily
10:30AM  Sanofi/Regeneron's Asthma Candidate Meets Goal in Study Zacks
09:07AM  Pharma Stock Roundup: PFE to Buy ARRY, RHHBY, MRK, AZN Drugs Get Regulatory Nod Zacks
07:18AM  The Daily Biotech Pulse: ContraVir's Volatile Ride Continues, Late-Stage Disappointment For Exelixis, Regeneron-Sanofi Breathe Easy Benzinga
Jun-20-19 09:47AM  The Zacks Analyst Blog Highlights: Alphabet, Amazon, Apple, Sanofi and Walgreens Zacks
Jun-19-19 08:09PM  Heres What Hedge Funds Think About Sanofi (SNY) Insider Monkey
10:52AM  Sanofi plans 466 job cuts as part of R&D reshuffle Reuters
09:07AM  Alphabet's Healthcare Push Gains Steam: Others Brace Up Zacks
Jun-18-19 10:54AM  Sanofi, Google Partner On Health Care-Focused Virtual Innovation Lab Benzinga
10:30AM  Sanofi Partners Google to Build Healthcare Innovation Lab Zacks
10:27AM  Protalix (PLX) Completes Enrollment in Fabry Disease Study Zacks
09:18AM  Novo Nordisk's Victoza Gets FDA Nod for Pediatric Patients Zacks
07:00AM  Market Morning: Trump Immigrant Roundup, Gold Threatens, Google Goes Pharma Market Exclusive
01:24AM  French drugmaker Sanofi, Google to use data tech for innovations Reuters
01:00AM  Google and Drugmaker Sanofi to Join Forces on Data Technologies Bloomberg
Jun-17-19 10:30PM  Sanofi/Google: pixel of health Financial Times
09:12AM  Regeneron (REGN) Presents Positive Data on Lymphoma Candidate Zacks
Jun-14-19 08:42AM  Pharma Stock Roundup: MRK Buys Small Cancer Biotech, RHHBY, MRK Drugs Get FDA Nod Zacks
Jun-13-19 06:40AM  Does Sanofi (EPA:SAN) Create Value For Shareholders? Simply Wall St.
Jun-11-19 09:03AM  Lilly Announces Tradjenta Cardiovascular Outcome Study Data Zacks
07:00AM  Canadian employers underestimate the presence of chronic disease in the workforce CNW Group
Jun-10-19 12:34PM  Sanofi (SNY) in Focus: Stock Moves 5.5% Higher Zacks
Jun-07-19 12:25PM  Sanofi's Leadership Transition: What You Need To Know Benzinga +5.49%
11:53AM  New Sanofi CEO 2019: 8 Things to Know About Paul Hudson InvestorPlace
10:59AM  Sanofi Taps Novartis Executive as CEO in Race for New Drugs Bloomberg
10:21AM  Pharma Stock Roundup: ASCO Update, FDA Nod for LLY's Emgality for Cluster Headache Zacks
09:09AM  Novartis Appoints New Pharma Unit Head, Gives Other Updates Zacks
07:24AM  The Daily Biotech Pulse: Vertex Bets Big On Gene-Editing Therapies, Sanofi Poaches Novartis For CEO Role, Relief In Europe for Endologix Benzinga
06:58AM  UPDATE 3-Drugmaker Sanofi hires Hudson from Novartis as CEO Reuters
04:40AM  UPDATE 1-European stocks head for best week in 2 months, Sanofi jumps Reuters
03:51AM  Sanofi appoints top Novartis executive as new chief Financial Times
03:33AM  European stocks recover after ECB disappointment Reuters
02:16AM  CORRECTED-UPDATE 2-Drugmaker Sanofi appoints Novartis' Hudson as CEO Reuters
01:16AM  Swiss drugmaker Novartis names new drug division head Reuters
Jun-06-19 03:09PM  Local biotech firm bought for up to $70M American City Business Journals
09:09AM  Was ASCO Quieter for Big Drug/Biotech Stocks This Year? Zacks
Jun-05-19 09:09AM  Glaxo's Nucala Gets CHMP Nod for 2 Self-Administered Options Zacks
Jun-04-19 11:52AM  Emergent (EBS) Wins HHS Contract to Supply VIGIV Product Zacks
11:50AM  Sanofi loses German patent case against Amgen over cholesterol drug Reuters
May-31-19 11:21AM  Small-Cap Biotechs Aim to Steal Spotlight at Cancer Meeting Bloomberg
May-30-19 08:28AM  Amarin Rises on Priority Review for Vascepa Label Expansion Zacks
May-29-19 10:52AM  BioMarin Announces Data on Hemophilia Candidate, Shares Fall Zacks
May-23-19 10:03AM  Alphabet to Aid Pharma Giants Enhance Clinical Trial Process Zacks
09:08AM  Lilly (LLY) Launches Half-Priced Version of Humalog Insulin Zacks
May-21-19 06:31AM  Is Sanofi (EPA:SAN) Trading At A 32% Discount? Simply Wall St.
May-16-19 08:20AM  Pfizer's Eczema Candidate Meets All Goals in Phase III Study Zacks
May-15-19 05:00PM  Sanofi oncology pipeline targeting various cancers highlighted at ASCO 2019 PR Newswire
08:04AM  Sanofi Joins Drugmakers' Bid to Treat Patients With Software Bloomberg
May-10-19 10:21AM  Inovio (INO) Q1 Earnings & Revenues Fall Short of Estimates Zacks
May-08-19 01:12PM  Sanofi Recognized by DiversityInc as a Top 50 Company PR Newswire
09:37AM  Here's the Bad News That Derailed Regeneron's Stock Motley Fool
08:45AM  Sanofi Announces Licensing of Dupixent® (dupilumab) in the EU for the Treatment of Severe Asthma With Type 2 Inflammation PR Newswire
May-07-19 11:52AM  Regeneron Pharmaceuticals Earnings: REGN Stock Drops on Q1 Miss InvestorPlace -5.28%
08:00AM  How To Trade Growth Stocks: The Easy Way To Check And Confirm Institutional Support Investor's Business Daily
May-06-19 04:15PM  A Single Rival Caused 2 Biopharma Stocks To Slip Here's Why Investor's Business Daily
09:21AM  The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo Zacks
May-03-19 03:41PM  Emergent (EBS) Earnings & Revenues Miss Estimates in Q1 Zacks
09:46AM  Drugmakers lobbying spending at 10-year high as Washington targets soaring prices MarketWatch
06:10AM  Pharma Stock Roundup: MRK, LLY, PFE Report Q1 Earnings, SNY, ABBV Drugs Get EU Nod Zacks
May-02-19 02:18PM  5 Biotech Stocks With Near-Term Catalysts Ahead Benzinga
10:00AM  Alnylam (ALNY) Reports Narrower-Than-Expected Loss in Q1 Zacks
08:16AM  The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data Benzinga
May-01-19 06:35PM  FDA approves Dengvaxia® for the prevention of dengue in individuals ages 9 through 16 living in U.S. endemic areas PR Newswire
09:28AM  What's in the Cards for Novavax (NVAX) This Earnings Season? Zacks
Sanofi provides therapeutic solutions worldwide. It offers Cerezyme and Cerdelga for Gaucher, Myozyme and Lumizyme for Pompe, Fabrazyme for Fabry, and Aldurazyme for mucopolysaccharidosis Type 1; and Aubagio, an immunomodulatory and Lemtrada, a monoclonal antibody for multiple sclerosis. It also provides Dupixent for atopic dermatitis; Kevzara for rheumatoid arthritis; Eloctate and Alprolix to treat hemophilia in adults and children; and Cablivi to treat acquired thrombotic thrombocytopenic purpura in adults. In addition, it offers Libtayo for metastatic cutaneous squamous cell carcinoma; Jevtana and Taxotere taxane for cancers; Eloxatin for colon cancer; Thymoglobulin, an immunosuppressive and immunomodulating agent; Mozobil, for hematologic malignancies; and Zaltrap, for metastatic colorectal cancer. Further, it provides Lantus, Toujeo, Apidra, and Insuman insulins; Amaryl sulfonylurea; Adlyxin/Lyxumia, a GLP-1 receptor agonist; Soliqua 100/33/Suliqua, an insulin glargine and lixisenatide combination to treat diabetes; Admelog/Insulin lispro insulin; Praluent, a cholesterol-lowering drug; and Multaq, an anti-arrhythmic drug for atrial fibrillation. Additionally, it offers Plavix for atherothrombotic conditions; Lovenox for the prophylaxis, venous thromboembolism, and acute coronary syndrome; Aprovel and CoAprovel anti-hypertensives; Renagel and Renvela for patients undergoing dialysis; Synvisc and Synvisc-One viscosupplements for osteoarthritis; Stilnox for insomnia; Allegra for seasonal allergic rhinitis and uncomplicated hives; and Depakine for epilepsy. It also provides generic products; and products for allergy, cough, cold, pain, nutrition, digestion, pediatrics, influenza, meningitis, travel, and endemic vaccines; and adult and adolescent boosters. The company has an alliance with Verily Life Sciences LLC. Sanofi was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sanofi10% OwnerMar 08Sale412.17131,11554,041,31620,723,717Mar 12 08:19 PM
Sanofi10% OwnerSep 06Sale406.68104,55242,519,24923,654,384Sep 10 05:01 PM